Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery

Area of Science:

• Orthopedic Surgery
• Vascular Medicine
• Pharmacology

Background:

• Venous thromboembolism (VTE) is a significant risk following total hip or knee arthroplasty.
• Current thromboprophylaxis administration is often inadequate, posing a clinical challenge.
• Balancing VTE prevention benefits against bleeding risks is complex.

Purpose of the Study:

• To highlight the challenges in current thromboprophylaxis practices after joint replacement.
• To explore how improved anticoagulant therapies could enhance patient outcomes.
• To address barriers to optimal VTE prevention in orthopedic surgery patients.

Main Methods:

• Review of existing clinical practices and challenges in VTE prophylaxis.
• Analysis of the risk-benefit profile of current anticoagulant agents.
• Discussion of potential improvements through novel anticoagulant formulations.

Main Results:

• Inadequate thromboprophylaxis administration is prevalent after total joint arthroplasty.
• Bleeding complications and agent inconvenience are major barriers to optimal use.
• Surgeons often adopt a conservative approach due to these challenges.

Conclusions:

• Simplifying anticoagulant therapy is crucial for improving VTE prevention.
• More convenient, effective, and safe agents could increase adherence to guidelines.
• Optimizing thromboprophylaxis can reduce serious complications after joint replacement surgery.